Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative sequential chemoradiotherapy versus chemotherapy alone after complete resection of stage IIIA pN2 non-small-cell lung cancer
ChiCTR-TRC-08000067Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel and cisplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: progression-free survival. Started Mar 2008; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-08000067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000067.